Safety and Efficacy of Baloxavir Marboxil in Influenza-infected Children 5–11 Years of Age: A Post Hoc Analysis of a Phase 3 Study

BACKGROUND: miniSTONE-2 (NCT03629184) was a global, phase 3, randomized, controlled study that investigated the safety and efficacy of single-dose baloxavir marboxil in otherwise healthy children 1–<12 years of age and showed a positive risk-benefit profile. This post hoc analysis evaluated the s...

Descripción completa

Detalles Bibliográficos
Autores principales: Baker, Jeffery B., Block, Stanley L., Cagas, Steven E., Macutkiewicz, Laura Burleigh, Collins, Colleen, Sadeghi, Mitra, Sarkar, Sriparna, Williams, Sarah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Antimicrobial Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10569673/
https://www.ncbi.nlm.nih.gov/pubmed/37595103
http://dx.doi.org/10.1097/INF.0000000000004062

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10569673/
https://www.ncbi.nlm.nih.gov/pubmed/37595103
http://dx.doi.org/10.1097/INF.0000000000004062

Ejemplares similares